✦ LIBER ✦

Continued ribavirin monotherapy following interferon–ribavirin combination therapy is not effective for chronic hepatitis C

✍ Scribed by Shinichi Kakumu

Book ID: 108138227
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 48 KB
Volume: 32
Category: Article
ISSN: 1386-6346
DOI: 10.1016/j.hepres.2005.03.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interferon-ribavirin combination therapy

Interferon-ribavirin combination therapy for chronic hepatitis C

✍ Solko W. Schalm; J. T. Brouwer; L. Chemello; A. Alberti; A. Bellobuono; G. Ideo; 📂 Article 📅 1996 🏛 Springer US 🌐 English ⚖ 466 KB

The significance of interferon and ribav

The significance of interferon and ribavirin combination therapy followed by interferon monotherapy for patients with chronic hepatitis C in Japan

✍ Naoki Hiramatsu; Akinori Kasahara; Fumihiko Nakanishi; Takashi Toyama; Masahiko 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB

Retreatment of patients with chronic hep

Retreatment of patients with chronic hepatitis C not responding to interferon/ribavirin combination therapy with daily interferon plus ribavirin plus amantadine

✍ Rudolf E Stauber; Harald Hofer; Franz Hackl; Kurt Schüze; Christian Datz; Karin 📂 Article 📅 2004 🏛 Springer Vienna 🌐 English ⚖ 738 KB

Limitation of combination therapy of int

Limitation of combination therapy of interferon and ribavirin for older patients with chronic hepatitis C

✍ Yoshiaki Iwasaki; Hiroshi Ikeda; Yasuyuki Araki; Toshiya Osawa; Keiji Kita; Masa 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB 👁 2 views

In contrast to the United States, Japanese patients with chronic hepatitis C currently treated with interferon are generally 10 to 15 years older. Older patients, however, tend to experience more frequent adverse events. This study was conducted to clarify the effect of patient age on the efficacy a

Adequate timing of ribavirin reduction i

Adequate timing of ribavirin reduction in patients with hemolysis during combination therapy of interferon and ribavirin for chronic hepatitis C

✍ Yasuji Arase; Kenji Ikeda; Fumitaka Suzuki; Yoshiyuki Suzuki; Satoshi Saitoh; Ma 📂 Article 📅 2004 🏛 Springer Japan 🌐 English ⚖ 171 KB

Effect of lactoferrin in patients with c

Effect of lactoferrin in patients with chronic hepatitis C: Combination therapy with interferon and ribavirin

✍ Masahiko Kaito; Motoh Iwasa; Naoki Fujita; Yoshinao Kobayashi; Yuji Kojima; Jiro 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB